OCF Yield % is calculated as Cash Flow from Operations divided by Market Capitalization. It is a financial solvency ratio that compares the operating cash flow a company is expected to earn against its market value.
The historical rank and industry rank for Glenmark Pharmaceuticals's OCF Yield % or its related term are showing as below:
NSE:GLENMARK'
s OCF Yield % Range Over the Past 10 Years
Min: 5.35 Med: 0 Max: 5.35
Current: 5.35
During the past 13 years, the highest OCF Yield % of Glenmark Pharmaceuticals was 5.35%. The lowest was 5.35%. And the median was %.
NSE:GLENMARK's OCF Yield % is ranked better than 61.87% of 1007
companies
in the Drug Manufacturers industry
Industry Median: 3.48
vs NSE:GLENMARK: 5.35
Similar to Earnings Yield %, OCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high operating cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.
Glenmark Pharmaceuticals OCF Yield % Related Terms
Glenmark Pharmaceuticals OCF Yield % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Glenmark Pharmaceuticals's OCF Yield %, along with its competitors' market caps and OCF Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Glenmark Pharmaceuticals OCF Yield % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Glenmark Pharmaceuticals's OCF Yield % distribution charts can be found below:
* The bar in red indicates where Glenmark Pharmaceuticals's OCF Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Glenmark Pharmaceuticals (NSE:GLENMARK) has a OCF Yield % of 5.35 as of Jul. 12, 2026. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on Glenmark Pharmaceuticals and its competitors. Over the past decade, Glenmark Pharmaceuticals' OCF Yield % has ranged from 5.35 to 5.35. According to the industry distribution chart, Glenmark Pharmaceuticals ranks #384 out of 1007 companies in the Drug Manufacturers industry, placing it in the top 38.1%.
Is Glenmark Pharmaceuticals' OCF Yield % too high?
Glenmark Pharmaceuticals' current OCF Yield % is 5.35. Over the past 10 years, this metric has ranged from a low of 5.35 to a high of 5.35. The Drug Manufacturers industry median OCF Yield % is 3.48. Glenmark Pharmaceuticals' value of 5.35 is 53.7% above this industry median. Based on the distribution chart, Glenmark Pharmaceuticals ranks #384 out of 1007 companies in the Drug Manufacturers industry, which is above the industry midpoint. Overall, Glenmark Pharmaceuticals has a GF Score™ of 87/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Glenmark Pharmaceuticals' OCF Yield % compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Glenmark Pharmaceuticals ranks #384 out of 1007 companies for OCF Yield %. This puts Glenmark Pharmaceuticals in the upper half of its industry. The industry median OCF Yield % is 3.48. Glenmark Pharmaceuticals' value of 5.35 is 53.7% above this benchmark. Historically, Glenmark Pharmaceuticals' own OCF Yield % has ranged from 5.35 to 5.35 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Yield % for a Drug Manufacturers company?
The median OCF Yield % among Drug Manufacturers companies is 3.48, based on 1,007 companies in the industry. Companies in the top quartile (top 25%) have a OCF Yield % significantly above this median, while those in the bottom quartile fall well below. However, OCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Glenmark Pharmaceuticals's current OCF Yield % of 5.35 is 53.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Yield % mean?
A high OCF Yield % can signal that a stock is expensive relative to its fundamentals. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on Glenmark Pharmaceuticals and its competitors. For the Drug Manufacturers industry, the median OCF Yield % is 3.48 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Glenmark Pharmaceuticals's current OCF Yield % is 5.35. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Glenmark Pharmaceuticals stock overvalued right now?
Based on GuruFocus' analysis, Glenmark Pharmaceuticals (NSE:GLENMARK) is currently considered Modestly Overvalued. The stock's GF Value™ is ₹1,987.71, compared to a current price of ₹2,282.90 — trading 14.9% above its estimated fair value. The current OCF Yield % is 5.35 and 53.7% above the Drug Manufacturers industry median of 3.48. Glenmark Pharmaceuticals' overall GF Score™ is 87/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Yield % calculated?
OCF Yield % is calculated from a company's financial statements. For Glenmark Pharmaceuticals (NSE:GLENMARK), the current OCF Yield % is 5.35 as of Jul. 12, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Glenmark Pharmaceuticals (NSE:GLENMARK) Overvalued in 2026?
Based on GuruFocus' analysis, Glenmark Pharmaceuticals stock appears to be overvalued.
The current stock price of ₹2,282.90 is trading 14.9% above its estimated GF Value™ of ₹1,987.71.
GuruFocus considers Glenmark Pharmaceuticals to be Modestly Overvalued.
Key valuation signals for NSE:GLENMARK:
OCF Yield %: 5.35
GF Value™: ₹1,987.71 vs. price of ₹2,282.90 (14.9% above fair value)
Industry Position: 53.7% above the Drug Manufacturers median (#384 of 1007)
No single metric tells the full story. See the NSE:GLENMARK stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Glenmark Pharmaceuticals Ltd is a specialty and generic drug manufacturing company. The company's research and development activity is focused on generating intellectual property assets that will help address unmet medical needs. Glenmark's product categories include novel molecular entities, formulations, and API products. The company considers merger and acquisition investment to be a potential component for expanding its research, development, manufacturing, and marketing capabilities. It has a business presence in different therapeutic areas such as dermatology, respiratory, oncology, diabetes, cardiovascular, and oral contraceptives among others. Geographically, it derives key revenue from India and the rest from North America, Latin America, Europe and the Rest of the world.
87GF Score
Get the complete analysis for NSE:GLENMARK
OCF Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:GLENMARK has been successfully added to your 
